Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb

Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb

You can call them "frenemies." 

Pfizer (NYSE: PFE) and Bristol-Myers Squibb (NYSE: BMY) are friends when it comes to blockbuster blood thinner Eliquis. But the two big pharma companies are enemies in the oncology and immunology arenas. 

How do these collaborators and competitors compare for investors? Here's how Pfizer and Bristol-Myers Squibb (BMS) stack up against each other.

Continue reading

Source: Fool.com